Structure Info
- Chemspace ID
- CSSS02125554581 (In-Stock Screening Compounds)
- MFCD
- MFCD26142941
- IUPAC Name
- 4-(2-aminoethoxy)-N2,N6-bis[4-(2-aminoethoxy)quinolin-2-yl]pyridine-2,6-dicarboxamide; trifluoroacetic acid
- Mol formula
- C33H33F3N8O7
- Mol weight
- 711 Da
- Catalog Number(s)
- A374986, AA01FS1V, ACS-2156, AG-B37269, AG01FS4N, AR01FSTN, AS-84270, AY15711, BD765593, BG15711, CD00009316, G72044, HY-15176B, P992185, R906036, S7444, T4470, XIC61144, Y1089360, Y1214052, Y228305, scs-2156
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.35
- Heavy atoms count
- 51
- Rotatable bond count
- 14
- Number of rings
- 5
- Carbon bond saturation, Fsp3
- 0.212
- Polar surface area (Å)
- 203
- Hydrogen bond acceptors count
- 11
- Hydrogen bond donors count
- 5
- Zoom the structure
- CSSS02125554581
Items Overall 12 items from 3 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
MedChemExpress | 10 days | United States To: | 99 | 5 mg | 93 | |
MedChemExpress | 10 days | United States To: | 99 | 10 mg | 140 | |
MedChemExpress | 10 days | United States To: | 99 | 25 mg | 280 | |
Description: Names: Pyridostatin (TFA); RR82 (TFA); Product Description: Pyridostatin (RR82) TFA is a G-quadruplex DNA stabilizing agent ( K d =490 nM) and can target DNA and RNA G4s in cells. Pyridostatin TFA promotes growth arrest in human cancer cells by inducing replication- and transcription-dependent DNA damage. Pyridostatin TFA targets the proto-oncogene Src. Pyridostatin TFA reduced SRC protein levels and SRC-dependent cellular motility in human breast cancer cells .; Target: G-quadruplex; CAS: 1472611-44-1 | ||||||
MedChemExpress EU | 10 days | Sweden To: | 99 | 5 mg | 98 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 10 mg | 148 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 25 mg | 295 | |
Description: Names: Pyridostatin (TFA); RR82 (TFA); Product Description: Pyridostatin (RR82) TFA is a G-quadruplex DNA stabilizing agent (Kd=490 nM) and can target DNA and RNA G4s in cells. Pyridostatin TFA promotes growth arrest in human cancer cells by inducing replication- and transcription-dependent DNA damage. Pyridostatin TFA targets the proto-oncogene Src. Pyridostatin TFA reduced SRC protein levels and SRC-dependent cellular motility in human breast cancer cells; Target: G-quadruplex; CAS: 1472611-44-1 | ||||||
Targetmol Chemicals Inc | 30 days | United States To: | 97 | 1 mg | 33 | |
Targetmol Chemicals Inc | 30 days | United States To: | 97 | 5 mg | 74 | |
Targetmol Chemicals Inc | 30 days | United States To: | 97 | 10 mg | 113 | |
Targetmol Chemicals Inc | 30 days | United States To: | 97 | 25 mg | 201 | |
Targetmol Chemicals Inc | 30 days | United States To: | 97 | 50 mg | 305 | |
Targetmol Chemicals Inc | 30 days | United States To: | 97 | 100 mg | 497 | |
Description: Pyridostatin Trifluoroacetate Salt is a G-quadruplexe stabilizer with Kd of 490 nM in a cell-free assay, which targets a series of proto-oncogenes including c-kit, K-ras and Bcl-2.; CAS: 1472611-44-1 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire